Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Akero Therapeutics Inc

Start price
Target price
Perf. (%)
€27.00
25.09.22
€16.00
31.12.24
2.96%
26.09.22

Could be very worthwhile Investment >20% year
GSK plc

Start price
Target price
Perf. (%)
€15.10
23.09.22
€10.00
31.12.24
0.48%
26.09.22

Could be worthwhile Investment >10% per year
Sanofi S.A.

Start price
Target price
Perf. (%)
€78.83
23.09.22
€65.00
31.12.24
-1.51%
26.09.22

Could be worthwhile Investment >10% per year
buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€44.49
23.09.22
€80.00
31.07.25
0.94%
23.09.22

Could be very worthwhile Investment >20% year
buy
Cidara Therapeutics Inc

Start price
Target price
Perf. (%)
€0.78
21.09.22
€3.00
30.04.23
-15.97%
26.09.22

Could be very worthwhile Investment >20% year
Novartis AG ADR

Start price
Target price
Perf. (%)
€79.40
21.09.22
€70.00
21.09.23
-2.02%
26.09.22

Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.05
20.09.22
€1.80
20.09.23
-4.81%
26.09.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Inovio Pharma

Start price
Target price
Perf. (%)
€1.88
20.09.22
€1.60
20.09.23
-7.80%
26.09.22

Probably not worthwhile Investment
EBIT decline/stagnation expected
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
buy
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€1.17
20.09.22
-
20.09.23
-7.91%
26.09.22

Risky Investment
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€228.00
20.09.22
€270.00
20.09.23
3.57%
26.09.22

buy
Intercept Pharmaceuticals

Start price
Target price
Perf. (%)
€16.65
20.09.22
€32.00
31.01.23
-7.21%
22.09.22

Could be very worthwhile Investment >20% year
buy
Larimar Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.18
20.09.22
€7.00
31.08.25
2.52%
26.09.22

Could be very worthwhile Investment >20% year
buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€8.64
19.09.22
€17.00
19.09.23
9.65%
26.09.22

Could be very worthwhile Investment >20% year
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€1.21
19.09.22
-
19.09.23
-2.94%
31.08.22

Could be very worthwhile Investment >20% year
Capable Management
Few uniques
Riot Blockchain Inc.

Start price
Target price
Perf. (%)
€6.20
19.09.22
-
19.09.23
12.53%
26.09.22

Very high cyclical dependencies
Risky Investment
buy
Abbott Laboratories

Start price
Target price
Perf. (%)
€103.36
19.09.22
€130.00
19.09.23
0.62%
26.09.22

Could be worthwhile Investment >10% per year
High dividend yield expected
Revenue growth >5% per year expected
Top 10 in its market
buy
Athersys Inc.

Start price
Target price
Perf. (%)
€1.87
19.09.22
€3.80
19.09.23
-21.10%
26.09.22

Could be very worthwhile Investment >20% year
buy
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€1.65
18.09.22
-
18.09.23
-2.92%
26.09.22

Risky Investment
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€64.59
16.09.22
-
16.09.23
-0.09%
26.09.22

buy
G1 Therapeutics

Start price
Target price
Perf. (%)
€15.76
13.09.22
-
13.09.23
-19.68%
26.09.22

buy
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€60.00
08.09.22
€80.00
31.12.24
-21.28%
26.09.22

Could be very worthwhile Investment >20% year
buy
Reata Pharmaceuticals Inc

Start price
Target price
Perf. (%)
€25.60
08.09.22
€40.00
31.12.24
-4.69%
22.09.22

Could be very worthwhile Investment >20% year
buy
Ardelyx Inc.

Start price
Target price
Perf. (%)
€1.29
08.09.22
€2.50
31.12.24
-8.70%
26.09.22

Could be very worthwhile Investment >20% year
Paion AG

Start price
Target price
Perf. (%)
€0.90
08.09.22
€0.000
08.09.23
-16.32%
26.09.22

Innovative
Future proof or reliable business model
Could be very worthwhile Investment >20% year
Strong uniques
Apellis Pharmaceuticals

Start price
Target price
Perf. (%)
€64.19
07.09.22
€35.00
31.12.24
-3.96%
26.09.22

Could be very worthwhile Investment >20% year